(Report ID: 150055) Drug interactions analysis of:
Medroxyprogesterone Acetate, Premarin, Provera, Prempro, EstraceMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,579 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 965 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 150055 | Jun, 28, 2006 | Not specified | Female |
List of drugs the patient takes:
| Drug |
Medroxyprogesterone Acetate |
Premarin |
Provera |
Prempro |
Estrace |
| Name |
Breast Cancer Female |
Results from eHealthMe: 965 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Breast Cancer Female | 299 (30.98%) |
Death: 0
Cancer: 102 (100.00% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 57 (55.88%) |
2 | Breast Cancer Metastatic | 23 (22.55%) |
3 | Breast Cancer Female | 10 (9.80%) |
4 | Depression | 10 (9.80%) |
5 | Uterine Leiomyoma | 9 (8.82%) |
6 | Mastectomy | 8 (7.84%) |
7 | Osteopenia | 8 (7.84%) |
8 | Fibrocystic Breast Disease | 7 (6.86%) |
9 | Pain | 7 (6.86%) |
10 | Breast Mass | 7 (6.86%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Estraderm | 33 |
2 | Cycrin | 26 |
3 | Climara | 14 |
4 | Femhrt | 5 |
5 | Prometrium | 5 |
6 | Synthroid | 4 |
7 | Prozac | 4 |
8 | Activella | 4 |
9 | Lipitor | 4 |
10 | Zoloft | 4 |
Death: 0
Cancer: 965 (100.00% of total reports)
| Name | Count (% of total reports) |
1 | Breast Cancer | 525 (54.40%) |
2 | Breast Cancer Female | 299 (30.98%) |
3 | Oestrogen Receptor Assay Positive | 94 (9.74%) |
4 | Progesterone Receptor Assay Positive | 73 (7.56%) |
5 | Breast Cancer Metastatic | 71 (7.36%) |
6 | Breast Cancer In Situ | 55 (5.70%) |
7 | Depression | 54 (5.60%) |
8 | Pain | 44 (4.56%) |
9 | Breast Mass | 41 (4.25%) |
10 | Anxiety | 37 (3.83%) |
| Name | Count |
1 | Estraderm | 312 |
2 | Cycrin | 296 |
3 | Climara | 188 |
4 | Vivelle | 133 |
5 | Femhrt | 123 |
6 | Activella | 119 |
7 | Estratab | 110 |
8 | Vagifem | 102 |
9 | Aygestin | 94 |
10 | Cenestin | 92 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
